The European Cancer Patient Coalition has launched an online education (eLearning) module for patient organisations and patient advocates. The module aims to equip our members and broader patient community with knowledge to participate in the Health Technology Assessment (HTA) of cancer treatments.
The module covers a range of information from medicines development process and their examination as part of HTA, why cancer treatments might be reimbursed in some countries but not in others, and how cancer patient organisations can get involved in the HTA. The module also covers the recent legislative developments on HTA at the EU level and the importance of involvement of patient organisations and patient advocates in Health Technology Assessments.
People living with cancer and their carers best understand the need for new therapies and their impact on quality of life. Their unique knowledge, perspectives and experiences are crucial in determining the value of new treatments in the Health Technology Assessment.
Check out the short introductory video below or scroll down to access the module.
To access the module visit: [ Ссылка ]
To find out more about HTA visit: [ Ссылка ]
